Canada Finalizes GMP Rules for API Manufacturers

Drug Industry Daily
A A
Active pharmaceutical ingredient (API) manufacturers operating in Canada must establish clearly defined and controlled manufacturing processes to ensure consistency under Health Canada’s newly finalized good manufacturing practices (GMP) guidelines.

To View This Article:

Login

Subscribe To Drug Industry Daily